Table 1.
Patients characteristics | Cirrhotic (n = 22) | Non-cirrhotic (n = 30) | p -value |
---|---|---|---|
Mean age | 55.1 ± 1.2 years | 52.1 ± 1.1 years | NS |
Female sex | n = 14 | n = 17 | NS |
BMI | 22.3 ± 1.3 Kg/m2 | 24.8 ± 1.4 Kg/m2 | NS |
Alcohol abuse (ALD, ASH) | n = 10(5.1 ± 1.0 AU) | n = 7(4.8 ± 0.9 AU) | NS |
HCV and HBV infection | n = 2; 1 | n = 2; 1 | NS |
Metabolic origin (NAFLD, NASH) | n = 8 | n = 16 | NS |
Autoimmune/ Cholangiopathies |
n = 0/1 | n = 2/2 | 0.05 |
LS grade 1, 2, 3 | N/A | n = 7; 15; 8 | N/A |
LF (F0-F1; F2-F3) | 18.1 ± 0.7 kPa (F4) |
n = 12 (4.4 ± 0.5 kPa) (F0-F1); n = 18 (10.8 ± 0.4 kPa) (F2-F3) |
N/A |
NS, not significant; BMI, body mass index; ALD, alcoholic liver disease; AU, alcohol unit per day; NAFLD, non-alcoholic fatty liver disease; LS, liver steatosis; N/A, not applicable; LF, liver fibrosis (assessed by transient elastography).